Evidence map›Paper›PMID 35262878›Full record

ArticleDermatology and therapy2022

Onychomycosis: Recommendations for Diagnosis, Assessment of Treatment Efficacy, and Specialist Referral. The CONSONANCE Consensus Project.

Bianca Maria Piraccini, Michela Starace, Adam I Rubin, Nilton Gioia Di Chiacchio, Matilde Iorizzo, Dimitris Rigopoulos, A working group of the European Nail Society

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Dermatology and therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06971341 (Retrospective Observational Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06971341 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Retrospective Observational Study in Patients With Onychomycosis Treated With Mycoclear® and Ciclopirox

TypeobservationalSponsorUniversity of BolognaRan2025 to 2025Enrolled80ConditionsOnychomycosis of Toenails
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Tinea pedis: an updated review.Drugs in context · 2023
    Review
  4. Article
  5. Novel and Investigational Treatments for Onychomycosis.Journal of fungi (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Bianca Maria PiracciniDermatology-IRCCS, Policlinico Sant'Orsola, Department of Specialized, Experimental and Diagnostic Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy. biancamaria.piraccini@unibo.it.ORCID http://orcid.org/0000-0001-6537-9689
Michela StaraceDermatology-IRCCS, Policlinico Sant'Orsola, Department of Specialized, Experimental and Diagnostic Medicine, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
Adam I RubinChildren's Hospital of Philadelphia, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Nilton Gioia Di ChiacchioFaculdade de Medicina do ABC, Santo André, Brazil.
Matilde IorizzoPrivate Dermatology Practice, Bellinzona/Lugano, Switzerland.
Dimitris RigopoulosDepartment of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens-Andreas Sygros Hospital, Athens, Greece.
A working group of the European Nail Society
Children's Hospital of Philadelphia · USHospital do Servidor Público Municipal · BRIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITNational and Kapodistrian University of Athens · GRUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOnychomycosis is the most common nail disorder in adults, with high recurrence and relapse rates. Its diagnosis may be difficult by non-experts because the clinical signs may overlap with other dermatoses. The treatment may be challenging, as it should be patient-tailored.

methodsAn online survey was conducted among European Nail Society (ENS) members to provide recommendations on the diagnosis and assessment of distal lateral subungual onychomycosis (DLSO) in non-specialized clinical environments, as well as recommendations for patient referral.

resultsDLSO diagnosis is predominantly based on clinical aspects, and microscopy and fungal culture are commonly employed to establish the diagnosis. Assessment of clinical features is the main method for DLSO follow-up, and the main criterion to define cure is a combination of mycologic cure and clinical cure. The most commonly selected treatments for onychomycosis include oral antifungals, topical antifungals, and nail debridement. According to the nail experts, predisposing factors of DLSO to be evaluated include concurrent tinea pedis diagnosis, immunocompromised status, and diabetes. The minimum clinical aspects to be evaluated for DLSO diagnosis should include subungual hyperkeratosis, white-yellow-orange subungual scales, and absence of salmon-pink coloration. Recommendations for clinical signs that should be evaluated to confirm treatment effectiveness include normal appearance and color of the nail, reduction or absence of scales under the nail, and absence of onycholysis. Recommendations for specialist referral include lack of treatment effectiveness, need of additional therapies, concurrent presence of other diseases or comorbidities, severe DLSO, and presence of a dermatophytoma or involvement of the nail matrix.

conclusionsAccording to the surveyed nail experts, after evaluating clinical signs and predisposing factors for DLSO, the diagnosis should include subungual hyperkeratosis, nail color (yellow-orange), and onycholysis and thickening. In cases of severe DLSO, when there is treatment failure, concomitant diseases/comorbidities, presence of a dermatophytoma or involvement of the nail matrix, or involvement of several/all nails, referral should be considered.

Indexed as

AntifungalsConsensusDermatophytesDiagnosisEuropean Nail SocietyOnychomycosisPrimary careReferralTreatment

Identifiers

PMID35262878
PMCPMC9021334
OpenAlexW4220730024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.